0023-9155 : Tazorac .5 mg/g Cutaneous Cream


NDC0023-9155
Labeler: Allergan, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tazorac
Dosage Form: Cutaneous Cream
Application #: NDA021184
Rev. Date: 


NDC Package Codes:

  • 0023-9155-15: 1 TUBE IN 1 CARTON (0023‑9155‑15) > 3.5 G IN 1 TUBE
  • 0023-9155-30: 1 TUBE IN 1 CARTON (0023‑9155‑30) > 30 G IN 1 TUBE
  • 0023-9155-60: 1 TUBE IN 1 CARTON (0023‑9155‑60) > 60 G IN 1 TUBE

Active Ingredients:

  • Tazarotene

Dosage Strength:

  • .5 mg/g

Pharmaceutical Classes:

  • Retinoid [EPC]
  • Retinoids [CS]

Related Products:

Based on records with the same trade name.
  • 0023-0042 Tazorac 1 mg/g Cutaneous Gel by Allergan, Inc.
  • 0023-3090 Tazorac 1 mg/g Cutaneous Gel by Allergan, Inc.
  • 0023-3091 Tazorac .5 mg/g Cutaneous Gel by Allergan, Inc.
  • 0023-8335 Tazorac .5 mg/g Cutaneous Gel by Allergan, Inc.
  • 0023-9156 Tazorac 1 mg/g Cutaneous Cream by Allergan, Inc.
  • 16110-042 Tazorac 1 mg/g Cutaneous Gel by Almirall, LLC
  • 16110-833 Tazorac .5 mg/g Cutaneous Gel by Almirall, LLC
  • 16110-915 Tazorac .05 mg/g Cutaneous Cream by Almirall, LLC
  • 16110-916 Tazorac .1 mg/g Cutaneous Cream by Almirall, LLC
  • 54868-4456 Tazorac 1 mg/g Oral Gel by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0023-9155 QR Code

< Prev: 0023-8842Next: 0023-9156 >




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.